WallStreetZenWallStreetZen

NYSEMKT: CANF
Can Fite Biopharma Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Can Fite Biopharma earnings were -$9.8M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest CANF earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CANF reported annual earnings of -$9.8M, with 24.7% growth.

CANF earnings history

Current Revenue
$405.0k
Current Earnings
-$9.8M
Current Profit Margin
-2,426.7%

CANF Return on Equity

Current Company
-178.2%
Current Industry
-31.4%
Current Market
28.9%
CANF's Return on Equity (-178.2%)... subscribe to Premium to read more.
High Return on Equity Performance

CANF Return on Assets

Current Company
-105.5%
Current Industry
-9.6%
CANF is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CANF announces earnings.

CANF Return on Capital Employed

Current Company
-144.89%
Current Industry
-3.7%
CANF has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CANF vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CANF-$9.76M-$9.83MN/A-$11.94
PULM-$5.16M-$5.16MN/A-$1.41
GOVX-$21.40M-$21.46MN/A-$22.40
BGMS-$2.99M-$14.09MN/A-$6.45
INDP-$20.85M-$20.85MN/A-$21.58
View Top Biotech Stocks

Can Fite Biopharma Earnings Reports & History FAQ

What were Can Fite Biopharma's earnings last quarter?

Can Fite Biopharma (NYSEMKT: CANF) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total CANF earnings for the quarter were N/A. In the same quarter last year, Can Fite Biopharma's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Can Fite Biopharma stock.

Is Can Fite Biopharma profitable or losing money?

As of the last Can Fite Biopharma earnings report, Can Fite Biopharma is currently losing money. Can Fite Biopharma's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$9.83 million, a 24.72% increase year over year.

What was CANF's earnings growth in the past year?

As of Can Fite Biopharma's earnings date in Q2 2026, Can Fite Biopharma's earnings has grown year over year. CANF earnings in the past year totalled -$9.83 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.